Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.
Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.
Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases"
Symposium Chairs: F. Blasi (Milan, Italy), S. Bonini (London, United Kingdom)
Aims: In this joint ERS/EMA symposium, the audience will:
- Gain a better understanding of the gaps and problems related to rare lung diseases (RLD) endpoints, and their effects on the development and on the regulatory assessment of medicines in this area;
- Increase their knowledge about the state-of-the-art and future clinical development perspectives in the areas of idiopathic pulmonary fibrosis (IPF), critical respiratory conditions and cystic fibrosis (CF); and
- Gain insight into regulatory requirements for development of new medicines in rare diseases.